Last edition
News about "Syntegon pharma business"
Syntegon Delivers Continued Sales Growth and Margin Expansion in First-Half
Syntegon reports 7 percent sales growth to €883 million in H1 2026, driven by a 14 percent increase in pharma sales and continued margin expansion.
Syntegon Pharma Business | 08/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members